Back

Women in cardiology leadership of randomized clinical trials and participation of women in late-breaking clinical trials: has the COVID-19 pandemic changed a thing or not exactly?

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardiovascular disease in women 2 Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Assistant Professor Biljana Parapid

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)

4 More presentations in this session

Presentation thumbnail
Sex differences in management and in-hospital outcomes in patients presenting with cardiogenic shock in a coronary care unit from a low to middle income country
Doctor M. Villalobos-Pedroza (Verona, IT)
Abstract Slides
Presentation thumbnail
The interplay of sex-specific electrophysiology and repolarization heterogeneity governs ventricular arrhythmia sustainability in women
Doctor V. Sobota (Brno, CZ)
Abstract Slides
Presentation thumbnail
Evaluation of cardiovascular disease in the turner syndrome population in Northern Ireland
Doctor A. Kearney (Belfast, GB)
Abstract Slides
Presentation thumbnail
Women with cardiogenic shock: risk factors and management in a tertiary center.
Doctor B. Diaz Arroyo (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular disease in women 2

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources